C1-inhibitor in Allergic ASThma Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 16, 2016

Primary Completion Date

October 23, 2019

Study Completion Date

October 23, 2019

Conditions
Asthma
Interventions
DRUG

C1-inhibitor

100 Unit/kg IV, one gift prior to broncho provocation.

OTHER

Saline

0.9% NaCl

DRUG

Antibiotics

vancomycin, ciprofloxacin, metronidazole

Trial Locations (1)

1105 AZ

Academic Medical Center, Amsterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Prothya Biosolutions

INDUSTRY

lead

T. van der Poll

OTHER